Rusan unveils APOSAN 3ml multi-dose pen
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories
It promises fewer injections for vision loss patients
Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
Subscribe To Our Newsletter & Stay Updated